BS
IBB icon

Banco Santander’s iShares Biotechnology ETF IBB Stock Holding History

Banco Santander’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
+6,846
New +$1.18M 0.01% 328
2023
Q2 		– Sell
-2,730
Closed -$353K – 417
2023
Q1 		$353K Buy
+2,730
New +$357K 0.01% 325
2017
Q1 		– Sell
-42,132
Closed -$3.58M – 145
2016
Q4 		$3.58M Buy
+42,132
New +$3.83M 0.09% 57

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Banco Santander's IBB Position: Q2 2026 in Review

Banco Santander opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 6,846 shares worth $1.3M. The stake represents 0.01% of the portfolio and ranks #328 among its holdings. This is a return to the name: Banco Santander previously reported a position in IBB as recently as Q1 2023.

Banco Santander first reported a position in IBB in Q4 2016 and has held it in 3 quarters since. The position peaked at $3.58M in Q4 2016. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Banco Santander held 6,846 shares of iShares Biotechnology ETF worth $1.3M as of Q2 2026.
  • iShares Biotechnology ETF was a new Banco Santander position in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Banco Santander's portfolio in Q2 2026, its #328 holding.
  • Banco Santander first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 3 quarters since.
  • Banco Santander's iShares Biotechnology ETF position peaked at $3.58M in Q4 2016.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.